Literature DB >> 7689990

Stabilization and expression of high levels of p53 during early development in Xenopus laevis.

F Tchang1, M Gusse, T Soussi, M Méchali.   

Abstract

We previously isolated a p53 cDNA from a Xenopus oocyte library. To determine if p53 has a function in the developmental period, we have studied its expression at the RNA and protein levels during the early development of Xenopus laevis. Two p53 transcripts (3 and 2.2 kb) are expressed from the beginning of Xenopus oogenesis, and the major one (2.2 kb) reaches a level of 7 x 10(5) to 7 x 10(6) transcripts per mature oocyte. After fertilization only the 2.2-kb RNA is detected, but its level decreases and at the neurula stage p53 RNA becomes undetectable. The p53 protein is highly expressed during Xenopus development, in contrast to an undetectable level in Xenopus cells in culture. Most of the p53 protein is synthesized during late oogenesis and a stage VI oocyte contains 7 x 10(11) molecules of p53 protein. This maternal p53 store is maintained at a constant level during Xenopus development, at least until the tadpole stage. This high level of expression is mainly due to stabilization of the p53 protein. Unusually for p53, the protein is strictly located in the cytoplasm of oocytes and this localization might indicate that it is stored in an inactive form at this stage. These data are discussed relative to previous observations made in transgenic mice.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7689990     DOI: 10.1006/dbio.1993.1230

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  9 in total

1.  The midblastula transition in Xenopus embryos activates multiple pathways to prevent apoptosis in response to DNA damage.

Authors:  C V Finkielstein; A L Lewellyn; J L Maller
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

Review 2.  Transcriptional control of terminal nephron differentiation.

Authors:  Samir S El-Dahr; Karam Aboudehen; Zubaida Saifudeen
Journal:  Am J Physiol Renal Physiol       Date:  2008-02-20

3.  Ionizing radiation induces apoptosis and elevates cyclin A1-Cdk2 activity before but not after the midblastula transition in Xenopus.

Authors:  J A Anderson; A L Lewellyn; J L Maller
Journal:  Mol Biol Cell       Date:  1997-07       Impact factor: 4.138

4.  Identification and characterization of a p53 homologue in Drosophila melanogaster.

Authors:  S Jin; S Martinek; W S Joo; J R Wortman; N Mirkovic; A Sali; M D Yandell; N P Pavletich; M W Young; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

5.  MicroRNA-125b is a novel negative regulator of p53.

Authors:  Minh T N Le; Cathleen Teh; Ng Shyh-Chang; Huangming Xie; Beiyan Zhou; Vladimir Korzh; Harvey F Lodish; Bing Lim
Journal:  Genes Dev       Date:  2009-03-17       Impact factor: 11.361

6.  A direct effect of activated human p53 on nuclear DNA replication.

Authors:  L S Cox; T Hupp; C A Midgley; D P Lane
Journal:  EMBO J       Date:  1995-05-01       Impact factor: 11.598

7.  A new invertebrate member of the p53 gene family is developmentally expressed and responds to polychlorinated biphenyls.

Authors:  Kathryn Jessen-Eller; Jill A Kreiling; Gail S Begley; Marjorie E Steele; Charles W Walker; Raymond E Stephens; Carol L Reinisch
Journal:  Environ Health Perspect       Date:  2002-04       Impact factor: 9.031

8.  Gene expression in Pre-MBT embryos and activation of maternally-inherited program of apoptosis to be executed at around MBT as a fail-safe mechanism in Xenopus early embryogenesis.

Authors:  Koichiro Shiokawa; Mai Aso; Takeshi Kondo; Hiroaki Uchiyama; Shinsaku Kuroyanagi; Jun-Ichi Takai; Senji Takahashi; Masayuki Kajitani; Chikara Kaito; Kazuhisa Sekimizu; Eiji Takayama; Kazuei Igarashi; Hiroshi Hara
Journal:  Gene Regul Syst Bio       Date:  2008-05-29

9.  Phosphorylation of p53 is regulated by TPX2-Aurora A in xenopus oocytes.

Authors:  Gaetan Pascreau; Frank Eckerdt; Andrea L Lewellyn; Claude Prigent; James L Maller
Journal:  J Biol Chem       Date:  2009-01-02       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.